Clinical trial
A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine
NCT00119743 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00119743 |
|---|---|
| Title | A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine |
| Official title | Assess, in Young Children, the Efficacy in Preventing Acute Otitis Media (AOM) of GSK Biologicals Undecavalent Pneumococcal-protein D Conjugate Vaccine, When Administered as a Three Dose Primary Vaccination Course During the First Year of Life With a Booster Dose in the Second Year of Life. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | undecavalent pneumococcal-protein D conjugate vaccine |
| Enrollment | 5,000 |
| Start date | Oct 1, 2000 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Jul 14, 2005 |
| Last update posted | Mar 23, 2017 |
| Countries | Czechia, Slovakia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: